These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 18387438

  • 1. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.
    Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS.
    J Am Coll Cardiol; 2008 Apr 08; 51(14):1369-74. PubMed ID: 18387438
    [Abstract] [Full Text] [Related]

  • 2. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):697-704. PubMed ID: 15734613
    [Abstract] [Full Text] [Related]

  • 3. [Association between delayed enhancement on cardiac magnetic resonance imaging and arrhythmia in patients with hypertrophic cardiomyopathy].
    WANG J, KONG XQ, XU HB, ZHOU GF, LIU F, SHI HJ, LIU DX.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep 01; 38(9):775-80. PubMed ID: 21092642
    [Abstract] [Full Text] [Related]

  • 4. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E, Marín F, González J, Gimeno JR, Feliu E, Romero A, Ruiz-Espejo F, Roldán V, Climent V, de la Morena G, Valdés M.
    J Card Fail; 2008 Jun 01; 14(5):414-9. PubMed ID: 18514934
    [Abstract] [Full Text] [Related]

  • 5. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
    Maron MS, Appelbaum E, Harrigan CJ, Buros J, Gibson CM, Hanna C, Lesser JR, Udelson JE, Manning WJ, Maron BJ.
    Circ Heart Fail; 2008 Sep 01; 1(3):184-91. PubMed ID: 19808288
    [Abstract] [Full Text] [Related]

  • 6. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, Bos JM, Tajik AJ, Valeti US, Nishimura RA, Gersh BJ.
    Circ Heart Fail; 2010 Jan 01; 3(1):51-8. PubMed ID: 19850699
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
    O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, Sheppard MN, Elliott PM, Pennell DJ, Prasad SK.
    J Am Coll Cardiol; 2010 Sep 07; 56(11):867-74. PubMed ID: 20688032
    [Abstract] [Full Text] [Related]

  • 8. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR, Tomé-Esteban M, Lofiego C, Hurtado J, Pantazis A, Mist B, Lambiase P, McKenna WJ, Elliott PM.
    Eur Heart J; 2009 Nov 07; 30(21):2599-605. PubMed ID: 19689975
    [Abstract] [Full Text] [Related]

  • 9. Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Pujadas S, Vidal-Perez R, Hidalgo A, Leta R, Carreras F, Barros A, Bayes-Genis A, Subirana MT, Pons-Llado G.
    Eur J Radiol; 2010 Aug 07; 75(2):e88-91. PubMed ID: 20079992
    [Abstract] [Full Text] [Related]

  • 10. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    McLELLAN AJ, Ellims AH, Prabhu S, Voskoboinik A, Iles LM, Hare JL, Kaye DM, Macciocca I, Mariani JA, Kalman JM, Taylor AJ, Kistler PM.
    J Cardiovasc Electrophysiol; 2016 May 07; 27(5):571-80. PubMed ID: 26840595
    [Abstract] [Full Text] [Related]

  • 11. Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging.
    Boonyasirinant T, Rajiah P, Setser RM, Lieber ML, Lever HM, Desai MY, Flamm SD.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):255-62. PubMed ID: 19589439
    [Abstract] [Full Text] [Related]

  • 12. Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.
    Appelbaum E, Maron BJ, Adabag S, Hauser TH, Lesser JR, Haas TS, Riley AB, Harrigan CJ, Delling FN, Udelson JE, Gibson CM, Manning WJ, Maron MS.
    Circ Cardiovasc Imaging; 2012 Jan 14; 5(1):78-85. PubMed ID: 22135401
    [Abstract] [Full Text] [Related]

  • 13. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A, Hindieh W, Spears DA, Adler A, Rakowski H, Chan RH.
    J Cardiovasc Electrophysiol; 2019 May 14; 30(5):651-657. PubMed ID: 30680853
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictors of syncope in patients with hypertrophic cardiomyopathy.
    Haghjoo M, Faghfurian B, Taherpour M, Fazelifar AF, Mohammadzadeh S, Alizadeh A, Sadr-Ameli MA.
    Pacing Clin Electrophysiol; 2009 May 14; 32(5):642-7. PubMed ID: 19422586
    [Abstract] [Full Text] [Related]

  • 17. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A, De Cobelli F, Perseghin G, Pieroni M, Belloni E, Mellone R, Canu T, Gentinetta F, Scifo P, Chimenti C, Frustaci A, Luzi L, Maseri A, Maschio AD.
    Heart; 2009 Mar 14; 95(3):228-33. PubMed ID: 18708417
    [Abstract] [Full Text] [Related]

  • 18. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.
    Biagini E, Coccolo F, Ferlito M, Perugini E, Rocchi G, Bacchi-Reggiani L, Lofiego C, Boriani G, Prandstraller D, Picchio FM, Branzi A, Rapezzi C.
    J Am Coll Cardiol; 2005 Oct 18; 46(8):1543-50. PubMed ID: 16226182
    [Abstract] [Full Text] [Related]

  • 19. Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Olivotto I, Maron BJ, Appelbaum E, Harrigan CJ, Salton C, Gibson CM, Udelson JE, O'Donnell C, Lesser JR, Manning WJ, Maron MS.
    Am J Cardiol; 2010 Jul 15; 106(2):261-7. PubMed ID: 20599013
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.